Basic breast cancer research is focus of new British research center

Reaching minority and underserved populations: the impact of the Cancer Information Service's outreach program. Part 3.

Journal of health communication·2000

National disasters. Home care's foray into nationwide HMO contracting takes a tumble.

Hospitals & health networks·1998

Cancer rarity and mortality: Evidence from a nationwide cohort study.

Journal of the National Cancer Institute·2026

Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer.

Journal of the National Cancer Institute·2026

Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.

Journal of the National Cancer Institute·2026

Predictive validity of a 10-item frailty index based on a comprehensive geriatric assessment (FI-CGA-10) in older Japanese adults with cancer.

Journal of the National Cancer Institute·2026

Association between genomic classifier scores and initial management of localized prostate cancer in the United States.

Journal of the National Cancer Institute·2026

Timing of mental disorders in relation to cancer-specific mortality in cancer patients.

Journal of the National Cancer Institute·2026

Exercise interventions remodel the aging microenvironment to improve prognosis in older patients with cancer.

Frontiers in immunology·2026

Dynamic junction remodeling and transient vascular disruption during cancer cell extravasation across the blood-brain barrier.

Frontiers in cell and developmental biology·2026

RUNX3+ basal-like malignant cells: architects of an immunosuppressive microenvironment in bladder cancer: a comprehensive bioinformatics analysis of single-cell and spatial transcriptomics.

International journal of surgery (London, England)·2026

CPT1A through succinylation regulates the CTCF/LINC01503‒91aa feedback loop to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.

Clinical and translational medicine·2026

CDK4/6 Inhibitors in the Management of Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer in Indonesia: Challenges, Opportunities, and Recommendations.

Asia-Pacific journal of clinical oncology·2026

Closing the gap in aging science: unlocking the potential of nanoparticles in senescence therapy.

Biogerontology·2026

Related Experiment Videos

Basic breast cancer research is focus of new British research center

Related Concept Videos

Reaching minority and underserved populations: the impact of the Cancer Information Service's outreach program. Part 3.

National disasters. Home care's foray into nationwide HMO contracting takes a tumble.

Cancer rarity and mortality: Evidence from a nationwide cohort study.

Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer.

Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.

Predictive validity of a 10-item frailty index based on a comprehensive geriatric assessment (FI-CGA-10) in older Japanese adults with cancer.

Association between genomic classifier scores and initial management of localized prostate cancer in the United States.

Timing of mental disorders in relation to cancer-specific mortality in cancer patients.

Exercise interventions remodel the aging microenvironment to improve prognosis in older patients with cancer.

Dynamic junction remodeling and transient vascular disruption during cancer cell extravasation across the blood-brain barrier.

RUNX3+ basal-like malignant cells: architects of an immunosuppressive microenvironment in bladder cancer: a comprehensive bioinformatics analysis of single-cell and spatial transcriptomics.

CPT1A through succinylation regulates the CTCF/LINC01503‒91aa feedback loop to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.

CDK4/6 Inhibitors in the Management of Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer in Indonesia: Challenges, Opportunities, and Recommendations.

Closing the gap in aging science: unlocking the potential of nanoparticles in senescence therapy.

Related Experiment Videos

Basic breast cancer research is focus of new British research center

Related Concept Videos

Related Articles